Research Papers Internet Impact On Society Of Hypertension

1.

Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA. 1970;213(7):1143–1152. [PubMed: 4914579]

2.

Effect of antihypertensive treatment on stroke recurrence. Hypertension-Stroke Cooperative Study Group. JAMA. 1974;229(4):409–418. [PubMed: 4599980]

3.

Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial. Plan and preliminary results of a two-year feasibility trial for a multicenter intervention study to evaluate the benefits versus the disadvantages of treating mild hypertension. Prepared for the Veterans Administration-National Heart, Lung, and Blood Institute Study Group for Evaluating Treatment in Mild Hypertension. Annals of the New York Academy of Sciences. 1978;304:267–292. [PubMed: 360921]

4.

The Australian therapeutic trial in mild hypertension. Report by the Management Committee. Lancet. 1980;1(8181):1261–1267. [PubMed: 6104081]

5.

Hydrochlorothiazide and bendroflumethiazide in low doses--a comparative trial. Acta Pharmacologica Et Toxicologica. 1984;54(Suppl 1):47–51. [PubMed: 6369883]

6.

An international trial of antihypertensive therapy in elderly patients. Objectives, protocol and organization. European Working Party on High Blood Pressure in the Elderly (EWPHE). Archives Internationales De Pharmacodynamie Et De Therapie. 1985;275(2):300–334. [PubMed: 3896176]

7.

Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH) The IPPPSH Collaborative Group. Journal of Hypertension. 1985;3(4):379–392. [PubMed: 2864374]

8.

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. BMJ. 1985;291(6488):97–104. [PMC free article: PMC1416260] [PubMed: 2861880]

9.

Course of blood pressure in mild hypertensives after withdrawal of long term antihypertensive treatment. Medical Research Council Working Party on Mild Hypertension. BMJ. 1986;293(6553):988–992. [PMC free article: PMC1341775] [PubMed: 2876745]

10.

Effects of replacing sodium intake in subjects on a low sodium diet: a crossover study. Australian National Health & Medical Research Council Dietary Salt Study Management Committee. Clinical and Experimental Hypertension Part A: Theory and Practice. 1989;11(5–6):1011–1024. [PubMed: 2676249]

11.

Fall in blood pressure with modest reduction in dietary salt intake in mild hypertension. Australian National Health and Medical Research Council Dietary Salt Study Management Committee. Lancet. 1989;1(8635):399–402. [PubMed: 2563786]

12.

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. New England Journal of Medicine. 1991;325(5):293–302. [PubMed: 2057034]

13.

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265(24):3255–3264. [PubMed: 2046107]

14.

Acute Pain Management: Operative or Medical Procedures and Trauma. Rockville, MD: Agency for Health Care Policy and Research Publications; 1992.

15.

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ. 1992;304(6824):405–412. [PMC free article: PMC1995577] [PubMed: 1445513]

16.

Systolic hypertension in the elderly: Chinese trial (syst-China). Interim report. Zhonghua Xin Xue Guan Bing Za Zhi. 1992;20(5):270–5. 323. [PubMed: 1306814]

17.

Systolic hypertension in the elderly: Chinese trial (Syst-China)--second interim report. Zhonghua Xin Xue Guan Bing Za Zhi. 1993;21(3):135–7. 185. [PubMed: 8243223]

18.

The Oslo Diet and Exercise Study (ODES): design and objectives. Controlled Clinical Trials. 1993;14(3):229–243. [PubMed: 8339552]

19.

Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke. The Dutch TIA Trial Study Group. Stroke. 1993;24(4):543–548. [PubMed: 8465360]

20.

Post-stroke antihypertensive treatment study. A preliminary result. PATS Collaborating Group. Chinese Medical Journal. 1995;108(9):710–717. [PubMed: 8575241]

21.

BS EN 1060-1: 1996 Specification for Non-Invasive Sphygmomanometers. General Requirements. Jun 15, 1996.

22.

Clinical and Experimental Pheochromocytoma. Cambridge, MA: Blackwell; 1996.

23.

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. European Heart Journal. 1998;19(10):1434–1503. [PubMed: 9820987]

24.

Health Survey for England: Cardiovascular Disease. The Stationary Office; 1999.

25.

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet. 2000;355(9200):253–259. [PubMed: 10675071]

26.

British National Formulary. Issue 44. BMJ Books and Pharmaceutical Press; Mar, 2001. 2003.

27.

Mulrow CD, editor. Evidence Based Hypertension. London: BMJ; 2001.

28.

Craig R, Mindell J, editors. Health Survey for England 2006. Volume 1: Cardiovascular Disease and Risk Factors in Adults. Leeds: The Information Centre; 2008. Available from: http://www​.ic.nhs.uk​/webfiles/publications​/HSE06/HSE%2006%20report​%20VOL%201%20v2.pdf.

29.

Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS) Hypertension Research. 2008;31(12):2115–2127. [PubMed: 19139601]

30.

NHS Supply Chain catalogue. [Last accessed on: 17 February 2010]. Available from: http://www​.supplychain​.nhs.uk/portal/page​/portal/Public/NHS-CAT.

31.

Achmon J, Granek M, Golomb M, Hart J. Behavioral treatment of essential hypertension: a comparison between cognitive therapy and biofeedback of heart rate. Psychosomatic Medicine. 1989;51(2):152–164. [PubMed: 2710909]

32.

Adsett CA, Bellissimo A, Mitchell A, Wilczynski N, Haynes RB. Behavioral and physiological effects of a beta blocker and relaxation therapy on mild hypertensives. Psychosomatic Medicine. 1989;51(5):523–536. [PubMed: 2678210]

33.

Agras WS, Southam MA, Taylor CB. Long-term persistence of relaxation-induced blood pressure lowering during the working day. Journal of Consulting and Clinical Psychology. 1983;51(5):792–794. [PubMed: 6355223]

34.

Agras WS, Taylor CB, Kraemer HC, Southam MA, Schneider JA. Relaxation training for essential hypertension at the worksite: II. The poorly controlled hypertensive. Psychosomatic Medicine. 1987;49(3):264–273. [PubMed: 3299443]

35.

Aitchison F, Page A. Diagnostic imaging of renal artery stenosis. Journal of Human Hypertension. 1999;13(9):595–603. [PubMed: 10482969]

36.

Aivazyan TA, Zaitsev VP, Salenko BB, Yurenev AP, Patrusheva IF. Efficacy of relaxation techniques in hypertensive patients. Health Psychology. 1988;7(Suppl):193–200. [PubMed: 3072179]

37.

Alam S, Johnson AG. A meta-analysis of randomised controlled trials (RCT) among healthy normotensive and essential hypertensive elderly patients to determine the effect of high salt (NaCl) diet of blood pressure. Journal of Human Hypertension. 1999;13(6):367–374. [PubMed: 10408586]

38.

Alderman MH, Davis TK, Gerber LM, Robb M. Antihypertensive drug therapy withdrawal in a general population. Archives of Internal Medicine. 1986;146(7):1309–1311. [PubMed: 3718126]

39.

Alem M, Milia P, Muir S, Lees K, Walters M. Comparison of the effects of diuretics on blood pressure and arterial stiffness in patients with stroke. Journal of Stroke and Cerebrovascular Diseases. 2008;17(6):373–377. [PubMed: 18984430]

40.

American Heart Association. 2000 Heart and Stroke Statistical Update. American Heart Association; 1999.

41.

ANSI/AAMI SP10 1987. Arlington, VA: Association for the Advancement of Medical Instrumentation; 1983. American National Standard for Electronic or Automated Sphymomanometers.

42.

Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyttere M, De SA, Dollery C, Fagard R, Forette F. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet. 1985;1(8442):1349–1354. [PubMed: 2861311]

43.

Amery A, Birkenhager W, Bulpitt CJ, Clement D, De Leeuw P, Dollery CT. Syst-Eur: a multicenter trial on the treatment of isolated systolic hypertension in the elderly objectives, protocol, and organisation. Ageing. 1991;3:287–302. [PubMed: 1764497]

44.

Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. American Heart Journal. 1991;121(1 Pt 2):293–298. [PubMed: 1985385]

45.

Anderssen S, Holme I, Urdal P, Hjermann I. Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES) Blood Pressure. 1995;4(6):343–349. [PubMed: 8746601]

46.

Antivalle M, Lattuada S, Salvaggio A, Paravicini M, Rindi M, Libretti A. Placebo effect and adaptation to noninvasive monitoring of BP. Journal of Human Hypertension. 1990;4(6):633–637. [PubMed: 2096204]

47.

Applegate WB, Miller ST, Elam JT, Cushman WC, el Derwi D, Brewer A, Graney MJ. Nonpharmacologic intervention to reduce blood pressure in older patients with mild hypertension. Archives of Internal Medicine. 1992;152(6):1162–1166. [PubMed: 1599343]

48.

Ara R, Brennan A. Economic Evaluation of Sibutramine for the Treatment of Obesity in Adults Without Other Co-Morbidities in the UK. School of Health and Related Research (ScHARR), University of Sheffield; 2004.

49.

Arima H, Chalmers J, Woodward M, Anderson C, Rodgers A, Davis S, Macmahon S, Neal B. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: The PROGRESS trial. Journal of Hypertension. 2006;24(6):1201–1208. [PubMed: 16685221]

50.

Arima H, Tanizaki Y, Yonemoto K, Doi Y, Ninomiya T, Hata J, Fukuhara M, Matsumura K, Iida M, Kiyohara Y. Impact of blood pressure levels on different types of stroke: the Hisayama study. Journal of Hypertension. 2009;27(12):2437–2443. [PubMed: 19657282]

51.

Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research. 4th ed. Oxford: Blackwell Science; 2002.

52.

Asagami T, Kushiro T, Inoue J, Kanmatsuse K. Long-term reproducibility and usefulness of daytime recording of noninvasive 24-hour ambulatory blood pressure monitoring in borderline hypertension: a two-year follow-up study. Clinical and Experimental Hypertension (New York) 1996;18(5):637–657. [PubMed: 8781751]

53.

Asayama K, Ohkubo T, Kikuya M, Obara T, Metoki H, Inoue R, Hara A, Hirose T, Hoshi H, Hashimoto J, Totsune K, Satoh H, Imai Y. Prediction of stroke by home "morning" versus "evening" blood pressure values: the Ohasama study. Hypertension. 2006;48(4):737–743. [PubMed: 16952977]

54.

Asayama K, Ohkubo T, Yoshida S, Suzuki K, Metoki H, Harada A, Murakami Y, Ohashi Y, Ueshima H, Imai Y. Japan Arteriosclerosis Longitudinal Study (JALS) group. Stroke risk and antihypertensive drug treatment in the general population: the Japan arteriosclerosis longitudinal study. Journal of Hypertension. 2009;27(2):357–364. [PubMed: 19155790]

55.

ASCOT Steering Committee. Age-Stratified Analysis of Blood Pressure Responses. Personal communication. p. 06.

56.

Asmar R, Safar M, Queneau P. Evaluation of the placebo effect and reproducibility of blood pressure measurement in hypertension. American Journal of Hypertension. 2001;14(6 I):546–552. [PubMed: 11411734]

57.

Assmann G, Cullen P, Evers T, Petzinna D, Schulte H. Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAM. European Heart Journal. 2005;26(20):2120–2126. [PubMed: 16141262]

58.

Ayman D, Goldshine AD. Blood pressure determination by patients with essential hypertension: the difference between clinic and home readings before treatment. American Journal of the Medical Sciences. 1940;200(4):465–474.

59.

Bamford J, Sandercock P, Dennis M, Warlow C, Jones L, McPherson K, Vessey M, Fowler G, Molyneux A, Hughes T. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981–86. 1. Methodology, demography and incident cases of first-ever stroke. Journal of Neurology, Neurosurgery & Psychiatry. 1988;51(11):1373–1380. [PMC free article: PMC1032805] [PubMed: 3266234]

60.

Barengo NC, Hu G, Kastarinen M, Antikainen R, Tuomilehto J. The effects of awareness, treatment and control of hypertension on future stroke incidence in a community-based population study in Finland. Journal of Hypertension. 2009;27(7):1459–1465. [PubMed: 19365282]

61.

Barengo NC, Kastarinen M, Antikainen R, Nissinen A, Tuomilehto J. The effects of awareness, treatment and control of hypertension on cardiovascular and all-cause mortality in a community-based population. Journal of Human Hypertension. 2009;23(12):808–816. [PubMed: 19369956]

62.

Bayo J, Cos FX, Roca C, Dalfo A, Martin-Baranera MM, Albert B. Home blood pressure self-monitoring: Diagnostic performance in white-coat hypertension. Blood Pressure Monitoring. 2006;11(2):47–52. [PubMed: 16534404]

63.

Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, Stoyanovsky V, Antikainen RL, Nikitin Y, Anderson C, Belhani A, Forette F, Rajkumar C, Thijs L, Banya W, Bulpitt CJ. HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. New England Journal of Medicine. 2008;358(18):1887–1898. [PubMed: 18378519]

64.

Beevers G, Lip G, O'Brien E. ABC of hypertension: Blood pressure measurement. Part II. BMJ. 2001;322(7293):1043–1047. [PMC free article: PMC1120188] [PubMed: 11325773]

65.

Beevers G, Lip GY, O'Brien E. ABC of hypertension. Blood pressure measurement. Part I-sphygmomanometry: factors common to all techniques. BMJ. 2001;322(7292):981–985. [PMC free article: PMC1120141] [PubMed: 11312235]

66.

Beevers G, Lip GY, O'Brien E. ABC of hypertension: The pathophysiology of hypertension. BMJ. 2001;322(7291):912–916. [PMC free article: PMC1120075] [PubMed: 11302910]

67.

Bejan-Angoulvant T, Saadatian-Elahi M, Wright JM, Schron EB, Lindholm LH, Fagard R, Staessen JA, Gueyffier F. Treatment of hypertension in patients 80 years and older: The lower the better? A meta-analysis of randomized controlled trials. Journal of Hypertension. 2010;28(7):1366–1372. [PubMed: 20574244]

68.

Benetos A, Thomas F, Bean KE, Guize L. Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population. Journal of Hypertension. 2003;21(9):1635–1640. [PubMed: 12923394]

69.

Bennett P, Wallace L, Carroll D, Smith N. Treating Type A behaviours and mild hypertension in middle-aged men. Journal of Psychosomatic Research. 1991;35(2–3):209–223. [PubMed: 2046054]

70.

Benson J, Britten N. Patients' decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ. 2002;325(7369):873. [PMC free article: PMC129637] [PubMed: 12386041]

71.

Benson J, Britten N. Patients' views about taking antihypertensive drugs: questionnaire study. BMJ. 2003;326(7402):1314–1315. [PMC free article: PMC161632] [PubMed: 12805171]

72.

Berglund A, Andersson OK, Berglund G, Fagerberg B. Antihypertensive effect of diet compared with drug treatment in obese men with mild hypertension. BMJ. 1989;299(6697):480–485. [PMC free article: PMC1837358] [PubMed: 2507028]

73.

Bhatnagar D, Anand IS, Durrington PN, Patel DJ, Wander GS, Mackness MI, Creed F, Tomenson B, Chandrashekhar Y, Winterbotham M, et al. Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India. Lancet. 1995;345(8947):405–409. [PubMed: 7853948]

74.

Bhopal R, Unwin N, White M, Yallop J, Walker L, Alberti KG, Harland J, Patel S, Ahmad N, Turner C, Watson B, Kaur D, Kulkarni A, Laker M, Tavridou A. Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ. 1999;319(7204):215–220. [PMC free article: PMC28170] [PubMed: 10417082]

75.

Bing RF, Briggs RS, Burden AC, Russell GI, Swales JD, Thurston H. Reversible hypertension and hypothyroidism. Clinical Endocrinology. 1980;13(4):339–342. [PubMed: 7438475]

76.

Bing RF, Russell GI, Swales JD, Thurston H. Indapamide and bendrofluazide: A comparison in the management of essential hypertension. British Journal of Clinical Pharmacology. 1981;12(6):883–886. [PMC free article: PMC1401924] [PubMed: 7041937]

77.

Bjorklund K, Lind L, Zethelius B, Berglund L, Lithell H. Prognostic significance of 24-h ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly men. Journal of Hypertension. 2004;22(9):1691–1697. [PubMed: 15311096]

78.

Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH Jr, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ. CONVINCE Research Group. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA. 2003;289(16):2073–2082. [PubMed: 12709465]

79.

Black HR, Elliott WJ, Neaton JD, Grandits G, Grambsch P, Grimm RH, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, White WB, Williams G, Wittes J, Zanchetti A, Fakouhi TD. Rationale and design for the controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial. Controlled Clinical Trials. 1998;19:370–390. [PubMed: 9683312]

80.

Blanchard EB, Miller ST, Abel GG, Haynes MR, Wicker R. Evaluation of biofeedback in the treatment of borderline essential hypertension. Journal of Applied Behavior Analysis. 1979;12(1):99–109. [PMC free article: PMC1311352] [PubMed: 468751]

81.

Bland JM, Jones DR, Bennett S, Haines AP, MacFarlane AJ. Is the clinical trial evidence about new drugs statistically adequate? British Journal of Clinical Pharmacology. 1985;19:155–160. [PMC free article: PMC1463709] [PubMed: 3872671]

82.

Turnbull F, Neal B, Ninomiya T, Algert C, Arima H, Barzi F, Bulpitt C, Chalmers J, Fagard R, Gleason A, Heritier S, Li N, Perkovic V, Woodward M, Macmahon S. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ. 2008;336(7653):1121–1123. [PMC free article: PMC2386598] [PubMed: 18480116]

83.

Bloom BS. Daily regimen and compliance with treatment. BMJ. 2001;323(7314):647. [PMC free article: PMC1121223] [PubMed: 11566816]

84.

Blumenthal JA, Sherwood A, Gullette EC, Babyak M, Waugh R, Georgiades A, Craighead LW, Tweedy D, Feinglos M, Appelbaum M, Hayano J, Hinderliter A. Exercise and weight loss reduce blood pressure in men and women with mild hypertension: effects on cardiovascular, metabolic, and hemodynamic functioning. Archives of Internal Medicine. 2000;160(13):1947–1958. [PubMed: 10888969]

85.

Blumenthal JA, Siegel WC, Appelbaum M. Failure of exercise to reduce blood pressure in patients with mild hypertension. Results of a randomized controlled trial. JAMA. 1991;266(15):2098–2104. [PubMed: 1920698]

86.

Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J, Mallion JM. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291(11):1342–1349. [PubMed: 15026401]

87.

Bobrie G, Genes N, Vaur L, Clerson P, Vaisse B, Mallion JM, Chatellier G. Is "isolated home" hypertension as opposed to "isolated office" hypertension a sign of greater cardiovascular risk? Archives of Internal Medicine. 2001;161(18):2205–2211. [PubMed: 11575977]

88.

Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Bjorklund-Bodegard K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Wang J, Sandoya E, O'Brien E, Staessen JA. International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO) investigators. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370(9594):1219–1229. [PubMed: 17920917]

89.

Borghi C, Dormi A, L'Italien G, Lapuerta P, Franklin SS, Collatina S, Gaddi A. The relationship between systolic blood pressure and cardiovascular risk--results of the Brisighella Heart Study. Journal of Clinical Hypertension. 2003;5(1):47–52. [PubMed: 12556653]

90.

Borhani NO, Mercuri M, Borhani PA, Buckalew VM, Canossa-Terris M, Carr AA, Kappagoda MD, Rocco MV, Schnaper HW, Sowers JR, Bond MG. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS) JAMA. 1996;276(10):785–791. [PubMed: 8769587]

91.

Borrello G, Mastroroberto P, Curcio F, Chello M, Zofrea S, Mazza ML. The effects of magnesium oxide on mild essential hypertension and quality of life. Current Therapeutic Research. 1996;57(10):767–774.

92.

Bosley F, Allen TW. Stress management training for hypertensives: cognitive and physiological effects. Journal of Behavioral Medicine. 1989;12(1):77–89. [PubMed: 2746644]

93.

Bowlus WE, Langford HG. A comparison of the antihypertensive effect of chlorthalidone and hydrochlorthiazide. Clinical Pharmacology and Therapeutics. 1964;5:708–711. [PubMed: 14226186]

94.

Brandao SA, Izar CO, Fischer SM, Santos AO, Monteiro CM, Povoa RM, Helfenstein T, Carvalho AC, Monteiro AM, Ramos E, Gidlund M, Figueiredo Neto AM, Fonseca FA. Early increase in autoantibodies against human oxidized low-density lipoprotein in hypertensive patients after blood pressure control. American Journal of Hypertension. 2010;23(2):208–214. [PubMed: 19910928]

95.

Brauer AP, Horlick L, Nelson E, Farquhar JW, Agras WS. Relaxation therapy for essential hypertension: a Veterans Administration Outpatient study. Journal of Behavioral Medicine. 1979;2(1):21–29. [PubMed: 400246]

96.

Bray EP, Holder R, Mant J, McManus RJ. Does self-monitoring reduce blood pressure? Meta-analysis with meta-regression of randomized controlled trials. Annals of Medicine. 2010;42(5):371–386. [PubMed: 20504241]

97.

Brenner BM, Cooper ME, de ZD, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New England Journal of Medicine. 2001;345(12):861–869. [PubMed: 11565518]

98.

Brenner H, Gefeller O. Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence. Stat Med. 1997;16(9):981–991. [PubMed: 9160493]

99.

British Hypertension Society. Blood Pressure Measurement CD-ROM. BMJ; 1999.

100.

British Hypertension Society. Validated devices suitable for home use. [Last accessed on: 11 November 2010]. Available from: http://www​.bhsoc.org​/blood_pressure_list.stm.

101.

Britton KA, Gaziano JM, Djousse L. Normal systolic blood pressure and risk of heart failure in US male physicians. European Journal of Heart Failure. 2009;11(12):1129–1134. [PMC free article: PMC2779833] [PubMed: 19861382]

102.

Bronnum-Hansen H, Davidsen M, Thorvaldsen P. Long-term survival and causes of death after stroke. Stroke. 2001;32(9):2131–2136. [PubMed: 11546907]

103.

Bronnum-Hansen H, Jorgensen T, Davidsen M, Madsen M, Osler M, Gerdes LU, Schroll M. Survival and cause of death after myocardial infarction: the Danish MONICA study. Journal of Clinical Epidemiology. 2001;54(12):1244–1250. [PubMed: 11750193]

104.

Brook RD. Home blood pressure: accuracy is independent of monitoring schedules. American Journal of Hypertension. 2000;13(6 Pt 1):625–631. [PubMed: 10912745]

105.

Brown MJ, Palmer CR, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) Lancet. 2000;356(5):366–372. [PubMed: 10972368]

106.

Brown MJ, Palmer CR, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T. Principal results from the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT) European Heart Journal. 2001;3(Suppl B):B20–B26.

107.

Bulpitt CJ, Ferrier G, Lewis PJ, Daymond M, Bulpitt PF, Dollery CT. Potassium supplementation fails to lower blood pressure in hypertensive patients receiving a potassium losing diuretic. Annals of Clinical Research. 1985;17(4):126–130. [PubMed: 3907484]

108.

Burgess E, Lewanczuk R, Bolli P, Chockalingam A, Cutler H, Taylor G, Hamet P. Lifestyle modifications to prevent and control hypertension. 6. Recommendations on potassium, magnesium and calcium. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. Canadian Medical Association Journal. 1999;160(9 Suppl):S35–S45. [PMC free article: PMC1230338] [PubMed: 10333852]

109.

Burke LE, Dunbar-Jacob JM, Hill MN. Compliance with cardiovascular disease prevention strategies: a review of the research. Annals of Behavioral Medicine. 1997;19(3):239–263. [PubMed: 9603699]

110.

Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension. 1995;25(3):305–313. [PubMed: 7875754]

111.

Calvo C, Hermida RC, Ayala DE, Lopez JE, Fernandez JR, Dominguez MJ, Mojon A, Covelo M. The 'ABPM effect' gradually decreases but does not disappear in successive sessions of ambulatory monitoring. Journal of Hypertension. 2003;21(12):2265–2273. [PubMed: 14654746]

112.

Campbell NC, Ritchie LD, Thain J, Deans HG, Rawles JM, Squair JL. Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care. Heart. 1998;80(5):447–452. [PMC free article: PMC1728827] [PubMed: 9930042]

113.

Campbell NR, Burgess E, Choi BC, Taylor G, Wilson E, Cleroux J, Fodor JG, Leiter LA, Spence D. Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. Canadian Medical Association Journal. 1999;160(9 Suppl):S1–S6. [PMC free article: PMC1230333] [PubMed: 10333847]

114.

Campbell P, Ghuman N, Wakefield D, Wolfson L, White WB. Long-term reproducibility of ambulatory blood pressure is superior to office blood pressure in the very elderly. Journal of Human Hypertension. 2010;24(11):749–754. [PMC free article: PMC2888732] [PubMed: 20200549]

115.

Canino E, Cardona R, Monsalve P, Perez AF, Lopez B, Fragachan F. A behavioral treatment program as a therapy in the control of primary hypertension. Acta Cientifica Venezolana. 1994;45(1):23–30. [PubMed: 8525757]

116.

Cappuccio FP, Cook DG, Atkinson RW, Strazzullo P. Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart. 1997;78(6):555–563. [PMC free article: PMC1892335] [PubMed: 9470870]

117.

Cappuccio FP, MacGregor GA. Does potassium supplementation lower blood pressure? A meta-analysis of published trials. Journal of Hypertension. 1991;9(5):465–473. [PubMed: 1649867]

118.

Cappuccio FP, Siani A, Strazzullo P. Oral calcium supplementation and blood pressure: an overview of randomized controlled trials. Journal of Hypertension. 1989;7(12):941–946. [PubMed: 2697729]

119.

Carlsson AC, Theobald H, Hellénius M, Wändell PE. Cardiovascular and total mortality in men and women with different blood pressure levels -A 26year followup. Blood Pressure. 2009;18(3):105–110. [PubMed: 19484620]

120.

Carson MA, Hathaway A, Tuohey JP, McKay BM. The effect of a relaxation technique on coronary risk factors. Behavioral Medicine. 1988;14(2):71–77. [PubMed: 3289645]

121.

Cavallini MC, Roman MJ, Blank SG, Pini R, Pickering TG, Devereux RB. Association of the auscultatory gap with vascular disease in hypertensive patients. Annals of Internal Medicine. 1996;124(10):877–883. [PubMed: 8610916]

122.

Celentano A, Galderisi M, Tammaro P, Mureddu GF, Garofalo M, de Divitiis O. Effects on casual and 24-h ambulatory blood pressure of slow-release nicardipine and chlorthalidone in arterial essential hypertension: double-blind, crossover study. International Journal of Clinical Pharmacology, Therapy, and Toxicology. 1990;28(5):190–196. [PubMed: 2365538]

123.

Celis H, De CP, Fagard R, Thijs L, Staessen JA. For how many days should blood pressure be measured at home in older patients before steady levels are obtained? Journal of Human Hypertension. 1997;11(10):673–677. [PubMed: 9400910]

124.

Celis H, Yodfat Y, Thijs L, Clement D, Cozic J, de Cort P, Forette F, Grégoire M, Heyrman J, Stibbe G, van den Haute M, Staessen J, Fagard R. The Syst-Eur Investigators. Antihypertensive therapy in older patients with isolated systolic hypertension: the Syst-Eur experience in general practice. Family Practice. 1996;13(2):138–143. [PubMed: 8732324]

125.

Chalmers J, Morgan T, Doyle A, Dickson B, Hopper J, Mathews J, Matthews G, Moulds R, Myers J, Nowson C, et al. Australian National Health and Medical Research Council dietary salt study in mild hypertension. Journal of Hypertension - Supplement. 1986;4(6):S629–S637. [PubMed: 3475429]

126.

Chapman N, Dobson J, Wilson S, Dahlof B, Sever PS, Wedel H, Poulter NR. Anglo-Scandinavian Cardiac Outcomes Trial Investigators. Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension. 2007;49(4):839–845. [PubMed: 17309946]

127.

Chaturvedi N, McKeigue PM, Marmot MG. Resting and ambulatory blood pressure differences in Afro-Caribbeans and Europeans. Hypertension. 1993;22(1):90–96. [PubMed: 8319998]

128.

Chesney MA, Black GW, Swan GE, Ward MM. Relaxation training for essential hypertension at the worksite: I. The untreated mild hypertensive. Psychosomatic Medicine. 1987;49(3):250–263. [PubMed: 3299442]

129.

Chien KL, Huang PJ, Chen MF, Chiang FT, Lai LP, Lee YT. Assessment of quality of life in a double-blind, randomized clinical trial of imidapril and captopril for hypertensive Chinese in Taiwan. Cardiovascular Drugs and Therapy. 2002;16(3):221–226. [PubMed: 12374900]

130.

Chou T. Wake up and smell the coffee. Caffeine, coffee, and the medical consequences. Western Journal of Medicine. 1992;157(5):544–553. [PMC free article: PMC1022034] [PubMed: 1441496]

131.

Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O'Brien E. Office versus Ambulatory Pressure Study Investigators. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. New England Journal of Medicine. 2003;348(24):2407–2415. [PubMed: 12802026]

132.

Cleroux J, Feldman RD, Petrella RJ. Lifestyle modifications to prevent and control hypertension. 4. Recommendations on physical exercise training. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. Canadian Medical Association Journal. 1999;160(9 Suppl):S21–S28. [PMC free article: PMC1230336] [PubMed: 10333850]

133.

Coats AJS, Radaelli A, Clark SJ, Conway J, Sleight P. The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension. Journal of Hypertension. 1992;10(4):385–391. [PubMed: 1316405]

134.

Coca A, Messerli FH, Benetos A, Zhou Q, Champion A, Cooper-DeHoff RM, Pepine CJ. Predicting stroke risk in hypertensive patients with coronary artery disease: a report from the INVEST. Stroke. 2008;39(2):343–348. [PMC free article: PMC2805179] [PubMed: 18162623]

135.

Collins R, Peto R, Macmahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335(8693):827–838. [PubMed: 1969567]

136.

Conen D, Ridker PM, Buring JE, Glynn RJ. Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ. 2007;335(7617):432. [PMC free article: PMC1962877] [PubMed: 17704543]

137.

Conen D, Tschudi P, Martina B. Twenty-four hour ambulatory blood pressure for the management of antihypertensive treatment: a randomized controlled trial. Journal of Human Hypertension. 2009;23(2):122–129. [PubMed: 18754021]

138.

Conlin PR, Chow D, Miller ER III, Svetkey LP, Lin PH, Harsha DW, Moore TJ, Sacks FM, Appel LJ. The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. American Journal of Hypertension. 2000;13(9):949–955. [PubMed: 10981543]

139.

Cook TD, Campbell DT. Quasi-Experimentation: Design and Analysis Issues for Field Settings. Chicago: Rand McNally; 1979.

140.

Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. BMJ. 1986;293(6555):1145–1151. [PMC free article: PMC1341855] [PubMed: 3094811]

141.

Costa FV, Ambrosioni E, Montebugnoli L, Paccaloni L, Vasconi L, Magnani B. Effects of a low-salt diet and of acute salt loading on blood pressure and intralymphocytic sodium concentration in young subjects with borderline hypertension. Clinical Science. 1981;61(Suppl 7):21s–23s. [PubMed: 7032811]

142.

Cottier C, Shapiro K, Julius S. Treatment of mild hypertension with progressive muscle relaxation. Predictive value of indexes of sympathetic tone. Archives of Internal Medicine. 1984;144(10):1954–1958. [PubMed: 6385893]

143.

Cramer JA. Consequences of intermittent treatment for hypertension: the case for medication compliance and persistence. American Journal of Managed Care. 1998;4(11):1563–1568. [PubMed: 10338902]

144.

Croft PR, Brigg D, Smith S, Harrison CB, Branthwaite A, Collins MF. How useful is weight reduction in the management of hypertension? Journal of the Royal College of General Practitioners. 1986;36(291):445–448. [PMC free article: PMC1960639] [PubMed: 3440987]

145.

Cruickshank JK, Beevers DG, Osbourne VL, Haynes RA, Corlett JC, Selby S. Heart attack, stroke, diabetes, and hypertension in West Indians, Asians, and whites in Birmingham, England. BMJ. 1980;281(6248):1108. [PMC free article: PMC1714562] [PubMed: 7427603]

146.

Cupples ME, McKnight A. Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk. BMJ. 1994;309(6960):993–996. [PMC free article: PMC2541257] [PubMed: 7950723]

147.

Curtin F, Altman DG, Elbourne D. Meta-analysis combining parallel and cross-over clinical trials. Statistics in Medicine. 2002;21(15):2131–2144. [PubMed: 12210629]

148.

Cushman WC, Cutler JA, Hanna E, Bingham SF, Follmann D, Harford T, Dubbert P, Allender PS, Dufour M, Collins JF, Walsh SM, Kirk GF, Burg M, Felicetta JV, Hamilton BP, Katz LA, Perry HM Jr, Willenbring ML, Lakshman R, Hamburger RJ. Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressure. Archives of Internal Medicine. 1998;158(11):1197–1207. [PubMed: 9625399]

149.

Cushman WC, Langford HG. Randomised controlled trial of potassium chloride versus placebo in mildly hypertensive blacks and whites. Circulation. 1988;78:Suppl II-370.

150.

Cuspidi C, Macca G, Michev I, Salerno M, Fusi V, Severgnini B, Corti C, Meani S, Valerio C, Magrini F, Zanchetti A. Short-term reproducibility of nocturnal non-dipping pattern in recently diagnosed essential hypertensives. Blood Pressure. 2002;11(2):79–83. [PubMed: 12035875]

151.

Cuspidi C, Meani S, Sala C, Valerio C, Fusi V, Zanchetti A, Mancia G. How reliable is isolated clinical hypertension defined by a single 24-h ambulatory blood pressure monitoring? Journal of Hypertension. 2007;25(2):315–320. [PubMed: 17211238]

152.

Cutler JA, Follmann D, Allender PS. Randomized trials of sodium reduction: an overview. American Journal of Clinical Nutrition. 1997;65(2 Suppl):643S–651S. [PubMed: 9022560]

153.

Cutler JA, Follmann D, Elliott P, Suh I. An overview of randomized trials of sodium reduction and blood pressure. Hypertension. 1991;17(1 Suppl):I27–I33. [PubMed: 1987008]

154.

Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen M, Omvik S, Wedel H. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:995–1003. [PubMed: 11937178]

155.

Dahlöf B, Hansson L, Lindholm LH, Schersten B, Wester PO, Ekbom T, Hedner T, de Faire U. STOP-Hypertension-2: a prospective intervention trial of newer versus older treatment alternatives in old patients with hypertension. Blood Pressure. 1993;2:136–141. [PubMed: 8180726]

156.

Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) Lancet. 1991;338(8778):1281–1285. [PubMed: 1682683]

157.

Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J. ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366(9489):895–906. [PubMed: 16154016]

158.

Davy BM, Melby CL, Beske SD, Ho RC, Davrath LR, Davy KP. Oat consumption does not affect resting casual and ambulatory 24-h arterial blood pressure in men with high-normal blood pressure to stage I hypertension. Journal of Nutrition. 2002;132(3):394–398. [PubMed: 11880561]

159.

Dawes MG, Coats AJ, Juszczak E. Daytime ambulatory systolic blood pressure is more effective at predicting mortality than clinic blood pressure. Blood Pressure Monitoring. 2006;11(3):111–118. [PubMed: 16702819]

160.

de Hoon JN, Vanmolkot FH, van den Ven LL, Van Bortel LM. Quality of life comparison between bisoprolol and nifedipine retard in hypertension. Cardiovascular Drugs and Therapy. 1997;11(3):465–471. [PubMed: 9310275]

161.

de Lame PA, Droussin AM, Thomson M, Verhaest L, Wallace S. The effects of enalapril on hypertension and quality of life. A large multicenter study in Belgium. Acta Cardiologica. 1989;44(4):289–302. [PubMed: 2552718]

162.

De Plaen JF, Detry JM. Hemodynamic effects of physical training in established arterial hypertension. Acta Cardiologica. 1980;35(3):179–188. [PubMed: 6969961]

163.

de Souza F, Muxfeldt E, Fiszman R, Salles G. Efficacy of spironolactone therapy in patients with true resistant hypertension. Hypertension. 2010;55(1):147–152. [PubMed: 19858405]

164.

Deary AJ, Schumann AL, Murfet H, Haydock SF, Foo RS, Brown MJ. Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs. Journal of Hypertension. 2002;20(4):771–777. [PubMed: 11910315]

165.

Deckers JW, Goedhart DM, Boersma E, Briggs A, Bertrand M, Ferrari R, Remme WJ, Fox K, Simoons ML. Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk. European Heart Journal. 2006;27(7):796–801. [PubMed: 16497685]

166.

Degl'innocenti A, Elmfeldt D, Hofman A, Lithell H, Olofsson B, Skoog I, Trenkwalder P, Zanchetti A, Wiklund I. Health-related quality of life during treatment of elderly patients with hypertension: results from the Study on COgnition and Prognosis in the Elderly (SCOPE) Journal of Human Hypertension. 2004;18(4):239–245. [PubMed: 15037872]

167.

Den Hond E, Celis H, Fagard R, Keary L, Leeman M, O'Brien E, Vandenhoven G, Staessen JA. Self-measured versus ambulatory blood pressure in the diagnosis of hypertension. Journal of Hypertension. 2003;21(4):717–722. [PubMed: 12658017]

168.

Denardo SJ, Gong Y, Nichols WW, Messerli FH, Bavry AA, Cooper-DeHoff RM, Handberg EM, Champion A, Pepine CJ. Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy. American Journal of Medicine. 2010;123(8):719–726. [PMC free article: PMC3008373] [PubMed: 20670726]

169.

Dennis M, Bamford J, Sandercock P, Warlow C. Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke. 1990;21(6):848–853. [PubMed: 2349586]

170.

Dennis MS, Bamford JM, Sandercock PA, Warlow CP. Incidence of transient ischemic attacks in Oxfordshire, England. Stroke. 1989;20(3):333–339. [PubMed: 2922771]

171.

Department of Health. Blood Pressure Measurement Devices - Mercury and Non-Mercury (MDA DB2000(03)). London: Department of Health; 2000.

172.

Department of Health. Medical Devices and Equipment Management: Repair and Maintenance Provision (MDA DB2000(02)). London: Department of Health; 2000.

173.

Department of Health. Exercise Referral Systems: a National Quality Assessment Framework. London: 2001.

174.

Department of Health. NHS reference costs 2008–09. Available from: http://www​.dh.gov.uk​/en/Publicationsandstatistics​/Publications​/PublicationsPolicyAndGuidance​/DH_111591.

175.

DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials. 1986;7(3):177–188. [PubMed: 3802833]

176.

Devereux RB, Dahlof B, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris KE, Edelman JM, Wachtell K. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation. 2004;110(11):1456–1462. [PubMed: 15326072]

177.

Dickerson JE, Hingorani AD, Ashby MJ, Palmer CR, Brown MJ. Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet. 1999;353(9169):2008–2013. [

  • 1.

    Padwal RS, Bienek A, McAlister FA, Campbell NR. Outcomes research task force of the Canadian Hypertension Education Program. Epidemiology of Hypertension in Canada: an update. Can J Cardiol. 2016;32:687–94.

  • 2.

    Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. J Am Med Assoc. 1996;275:1571–6.

  • 3.

    Joffres M, Falaschetti E, Gillespie C, Robitaille C, Loustalot F, Poulter N, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. Br Med J Open. 2013;3:e003423.

  • 4.

    Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2015;387:957–67.

  • 5.

    Cloutier L, Daskalopoulou SS, Padwal RS, Lamarre-Cliche M, Bolli P, McLean D, et al. A new algorithm for the diagnosis of hypertension in Canada. Can J Cardiol. 2015;31:620–30.

  • 6.

    Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, et al. Hypertension Canada’s 2016 Canadian Hypertension Education Program Guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2016;32:569–88.

  • 7.

    Niiranen TJ, Hänninen M-R, Johansson J, Reunanen A, Jula AM. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study. Hypertension. 2010;55:1346–51.

  • 8.

    Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens. 1998;16:971–5.

  • 9.

    Stergiou GS, Baibas NM, Kalogeropoulos PG. Cardiovascular risk prediction based on home blood pressure measurement: the Didima study. J Hypertens. 2007;25:1590–6.

  • 10.

    Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. J Am Med Assoc. 2004;291:1342–9.

  • 11.

    Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777–83.

  • 12.

    Ohkubo T, Asayama K, Kikuya M, Metoki H, Hoshi H, Hashimoto J, et al. How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J Hypertens. 2004;22:1099–104.

  • 13.

    Bancej CM, Campbell N, McKay DW, Nichol M, Walker RL, Kaczorowski J. Home blood pressure monitoring among Canadian adults with hypertension: results from the 2009 Survey on Living with Chronic Diseases in Canada. Can J Cardiol. 2010;26:e152–7.

  • 14.

    Nordmann A, Frach B, Walker T, Martina B, Battegay E. Reliability of patients measuring blood pressure at home: prospective observational study. Br Med J. 1999;319:1172–1172.

  • 15.

    O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731–68.

  • 16.

    Chatellier G, Day M, Bobrie G, Menard J. Feasibility study of N-of-1 trials with blood pressure self-monitoring in hypertension. Hypertension. 1995;25:294–301.

  • 17.

    Stergiou GS, Nasothimiou EG, Kalogeropoulos PG, Pantazis N, Baibas NM. The optimal home blood pressure monitoring schedule based on the Didima outcome study. J Hum Hypertens. 2010;24:158–64.

  • 18.

    Niiranen TJ, Asayama K, Thijs L, Johansson JK, Hara A, Hozawa A, et al. Optimal number of days for home blood pressure measurement. Am J Hypertens. 2015;28:595–603.

  • 19.

    Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens. 2010;24:779–85.

  • 20.

    Imai Y, Kario K, Shimada K, Kawano Y, Hasebe N, Matsuura H, et al. The Japanese Society of Hypertension Guidelines for self-monitoring of blood pressure at home (second edition). Hypertens Res. 2012;35:777–95.

  • 21.

    National Institute of Health and Clinical Excellence. Hypertension: clinical management of primary hypertension in adults. In. London: NICE: NICE clinical guideline 127, 2011.

  • 22.

    Mengden T, Hernandez Medina RM, Beltran B, Alvarez E, Kraft K, Vetter H. Reliability of reporting self-measured blood pressure values by hypertensive patients. Am J Hypertens. 1998;11:1413–7.

  • 23.

    Milot JP, Birnbaum L, Larochelle P, Wistaff R, Laskine M, Van Nguyen P, et al. Unreliability of home blood pressure measurement and the effect of a patient-oriented intervention. Can J Cardiol. 2015;31:658–63.

  • 24.

    Myers MG, Stergiou GS. Reporting bias: Achilles’ heel of home blood pressure monitoring. J Am Soc Hypertens. 2014;8:350–7.

  • 25.

    Kallioinen N, Hill A, Horswill MS, Ward HE, Watson MO. Sources of inaccuracy in the measurement of adult patients’ resting blood pressure in clinical settings: a systematic review. J Hypertens. 2017;35:421–41.

  • 0 Thoughts to “Research Papers Internet Impact On Society Of Hypertension

    Leave a comment

    L'indirizzo email non verrà pubblicato. I campi obbligatori sono contrassegnati *